Multicenter study demonstrates that AI-based sarcopenia assessment predicts mortality in localized bladder cancer, indicating its clinical relevance.
AI-based assessment of sarcopenia is feasible, reliable, and reproducible. Sarcopenia according to Prado's criteria is associated with mortality in bladder cancer. Further multivariable validation in larger patient populations is needed to determine the prognostic value of AI-based body composition analysis.
No takes yet. Share an insight, caveat, or question.
Blondeau et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: